Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1992 | 12-1991 | 12-1990 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,576 | N/A | -4,051 | -1,282 | -1,785 |
| Depreciation Amortization | 554 | N/A | 311 | 48 | 17 |
| Other Working Capital | 347 | N/A | 244 | 204 | -81 |
| Other Operating Activity | 0 | -6,516 | 13 | 72 | 0 |
| Operating Cash Flow | $-7,675 | $-6,516 | $-3,484 | $-958 | $-1,849 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -232 | -358 | -797 | -55 | -33 |
| Other Investing Activity | 2,916 | -8,195 | 0 | 0 | 0 |
| Investing Cash Flow | $2,684 | $-8,553 | $-797 | $-55 | $-33 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 0 | N/A | -220 | N/A | N/A |
| Other Financing Activity | 8,448 | 14,872 | 2,621 | 3,940 | 1,462 |
| Financing Cash Flow | $8,448 | $14,872 | $2,400 | $3,940 | $1,462 |
| Beginning Cash Position | 2,678 | N/A | 3,164 | 237 | 657 |
| End Cash Position | 6,135 | N/A | 1,284 | 3,164 | 237 |
| Net Cash Flow | $3,457 | $-197 | $-1,880 | $2,927 | $-421 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,675 | -6,516 | -3,484 | -958 | -1,849 |
| Free Cash Flow | -7,675 | -6,516 | -3,484 | -958 | -1,849 |